| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |